• Login
    ARAN - Access to Research at NUI Galway
    View Item 
    •   ARAN Home
    • Support Services
    • Externally hosted open access publications with NUI Galway authors (2)
    • View Item
    •   ARAN Home
    • Support Services
    • Externally hosted open access publications with NUI Galway authors (2)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ARANCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsTypesThis CollectionBy Issue DateAuthorsTitlesSubjectsTypes

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Help

    How to submit and FAQs

    Reverse transcriptase drug resistance mutations in hiv-1 subtype c infected patients on art in karonga district, malawi

    Thumbnail
    View/Open
    Full Text
    Date
    2011-01-01
    Author
    Bansode, Vijay B
    Travers, Simon AA
    Crampin, Amelia C
    Ngwira, Bagrey
    French, Neil
    Glynn, Judith R
    McCormack, Grace P
    Metadata
    Show full item record
    Usage
    This item's downloads: 0 (view details)
    Cited 1 times in Scopus (view citations)
    
    Recommended Citation
    Bansode, Vijay B; Travers, Simon AA; Crampin, Amelia C; Ngwira, Bagrey; French, Neil; Glynn, Judith R; McCormack, Grace P (2011). Reverse transcriptase drug resistance mutations in hiv-1 subtype c infected patients on art in karonga district, malawi. AIDS Research and Therapy 8 ,
    Published Version
    https://aidsrestherapy.biomedcentral.com/track/pdf/10.1186/1742-6405-8-38?site=aidsrestherapy.biomedcentral.com
    Abstract
    Background: Drug resistance testing before initiation of, or during, antiretroviral therapy (ART) is not routinely performed in resource-limited settings. High levels of viral resistance circulating within the population will have impact on treatment programs by increasing the chances of transmission of resistant strains and treatment failure. Here, we investigate Drug Resistance Mutations (DRMs) from blood samples obtained at regular intervals from patients on ART (Baseline-22 months) in Karonga District, Malawi. One hundred and forty nine reverse transcriptase (RT) consensus sequences were obtained via nested PCR and automated sequencing from blood samples collected at three-month intervals from 75 HIV-1 subtype C infected individuals in the ART programme. Results: Fifteen individuals showed DRMs, and in ten individuals DRMs were seen from baseline samples (reported to be ART naive). Three individuals in whom no DRMs were observed at baseline showed the emergence of DRMs during ART exposure. Four individuals who did show DRMs at baseline showed additional DRMs at subsequent time points, while two individuals showed evidence of DRMs at baseline and either no DRMs, or different DRMs, at later timepoints. Three individuals had immune failure but none appeared to be failing clinically. Conclusion: Despite the presence of DRMs to drugs included in the current regimen in some individuals, and immune failure in three, no signs of clinical failure were seen during this study. This cohort will continue to be monitored as part of the Karonga Prevention Study so that the long-term impact of these mutations can be assessed. Documenting proviral population is also important in monitoring the emergence of drug resistance as selective pressure provided by ART compromises the current plasma population, archived viruses can re-emerge
    URI
    http://hdl.handle.net/10379/10345
    Collections
    • Externally hosted open access publications with NUI Galway authors (2)
    • Copyright @ NUI Galway
    • Library
    • NUI Galway